SÜSS MicroTec (SMHN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 May, 2026Company profile and strategic positioning
Headquartered in Germany with a 75-year history of innovation, serving the global semiconductor industry, especially in Asia.
Acts as a key technology provider for both frontend and advanced backend semiconductor processes.
Maintains strong partnerships with global IDMs, foundries, and research institutions.
Management board oversees finance, sales, R&D, production, and ESG initiatives.
Product portfolio and innovation
Offers solutions in photomask equipment, imaging, coating, and bonding for both frontend and backend segments.
Market leader in temporary and hybrid wafer bonding, with recent launches targeting high-volume manufacturing and R&D.
Upcoming product introductions include advanced photomask cleaning, hybrid bonding, and inkjet coating platforms.
Focused on supporting next-generation semiconductor nodes and advanced packaging technologies.
Financial performance and outlook
Q1 2026 order intake reached €149.3m (+69.5% YoY), but sales declined 30.7% YoY to €86.5m.
Gross profit margin for Q1 2026 was 36.1%, with EBIT margin at 4.3%, both down from prior year due to lower cost coverage.
2026 is expected to be a transition year with sales guidance of €425–485m, gross margin 35–37%, and EBIT margin 8–10%.
Long-term ambitions for 2030 include sales of €750–900m, gross margin 43–45%, and EBIT margin 20–22%.
Latest events from SÜSS MicroTec
- Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 202613 May 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference15 Apr 2026 - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation13 Apr 2026 - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 20252 Apr 2026 - Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Q1 2025 sales up 31.8%, profit surged, but order intake fell amid rising macro risks.SMHN
Q1 202521 Nov 2025